Tau protein in normal and Alzheimer's disease brain: An update

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 329-351

  Johnson, G V W ^a   Hartigan, J A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Kinase; Microtubule; PHF; Phosphatase; Phosphorylation

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CEREBROSPINAL FLUID ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033302735     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-512     Document Type: Review

References (176)

1. A radiation hybrid map of the BRCA1 region of chromosome 17q12-q21
2. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
3. A tau promoter region without neuronal specificity
4. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures
5. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
6. Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease
7. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine
8. Role of glycosaminoglycans in determining the helicity of paired helical filaments
9. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation
10. Role of oxidative stress in development of complications in diabetes
11. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
12. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with lateonset FAD
13. Tau is enriched on dynamic microtubules in the distal region of growing axons
14. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?
15. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up
16. Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation
17. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes
18. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease
19. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding
20. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
21. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology
22. Expression of tau exon 8 in different species
23. Genetic evidence for the involvement of tau in progressive supranuclear palsy
24. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
25. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
26. Microtubule-associated protein 2c reorganizes both microtubules and microfilaments into distinct cytological structures in an actin-binding protein-280-deficient melanoma cell line
27. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures
28. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and betaamyloid in primary rat cortical neuronal cultures
29. Microfilament-associated growth cone component depends upon Tau for its intracellular localization
30. MARK, a novel family of protein kinases that phosphorylate microtubuleassociated proteins and trigger microtubule disruption
31. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau
32. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
33. Domains of neuronal microtubule-associated proteins and flexural rigidity of microtubules
34. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau
35. Modulation of the phosphorylation state of tau in situ: The roles of calcium and cyclic AMP
36. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
37. 2+ accumulation
38. Beta PP and Tau interaction, A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease
39. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
40. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
41. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
42. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
43. Cloning and sequencing of the cDNA encoding an isoform of microtubuleassociated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
44. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
45. Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain
46. Phosphoprotein phosphatase activities in Alzheimer disease brain
47. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly
48. Tan is widely expressed in rat tissues
49. Domains of tau protein and interactions with microtubules
50. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ
51. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
52. Amyloid, the presenilins and Alzheimer's disease
53. Alzheimer-like changes in microtubuleassociated protein Tau induced by sulfated glycosaminoglycans, Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation
54. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein
55. Characterization of two distinct monoclonal antibodies to paired helical filaments: Further evidence for fetal-type phosphorylation of the tau in paired helical filaments
56. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: A genetic and clinicopathological study of three Dutch families
57. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alphasynuclein gene
58. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
59. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3
60. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
61. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain
62. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17
63. Activation of phospholipase C-gamma by the concerted action of tan proteins and arachidonic acid
64. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's Disease
65. Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1
66. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments
67. Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau
68. Tau proteins bind to kinesin and modulate its activation by microtubules
69. Tau complexes withphospholipase C-γ in situ
70. Increased cerebrospinal fluid tau in patients with Alzheimer's disease
71. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau
72. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease
73. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments
74. Tau protein in normal and Alzheimer's disease brain
75. Phosphorylation of tan protein
76. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
77. Fetal-type phosphorylation of the tau in paired helical filaments
78. The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques
79. Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner
80. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments
81. A molecular mechanism for the effect of lithium on development
82. Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells
83. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes
84. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy
85. Casein kinase 1 is tightly associated with paired-helical filaments isolated from Alzheimer's disease brain
86. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease
87. Betamyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein
88. A68: A major subunit of paired helical filaments and derivatized forms of normal Tau
89. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau
90. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
91. Phosphorylation of tau in situ: Inhibition of calcium-dependent proteolysis
92. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: The effects on the organization and stability of microtubules
93. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
94. Tau as a marker for Alzheimer's disease
95. A spatial gradient of tau protein phosphorylation in nascent axons
96. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
97. Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
98. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubuleassociated protein tau
99. Calciumdestabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF
100. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases
101. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex
102. ptl-1, A Caenorhabditis elegans gene whose products are homologous to the tau microtubule-associated proteins
103. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A
104. Protection against b-amyloid toxicity in primary neurons by paclitaxel (Taxol)
105. E-4-hydroxy-2nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures
106. Tau in cerebrospinal fluids: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau
107. Proline-directed and non-proline-directed phosphorylation of PHF-tau
108. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
109. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
110. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease
111. Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17
112. Characterization of in vitro glycation sites of tau
113. Molecular evolution of tau protein: Implications for Alzheimer's disease
114. Cerebrospinal fluid levels of amyloid betaprotein in Alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype
115. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
116. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
117. The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase
118. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain
119. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction
120. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
121. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls
122. Tau is a candidate gene for chromosome 17 frontotemporal dementia
123. The 'jaws' model of tau-microtubule interaction examined in CHO cells
124. Autosomal dominant dementia with widespread neurofibrillary tangles
125. Reactivating kinase/p38 phosphorylates tau protein in vitro
126. Stress-activated protein kinase/cjun N-terminal kinase phosphorylates tau protein
127. Cerebrospinal protein tau is elevated in early Alzheimer's disease
128. Activation of ml muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells
129. Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports
130. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
131. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Aizheimer disease
132. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau
133. Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: A study with quantitative magnetic resonance imaging
134. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments
135. Phosphorylation of recombinant tau by cAMP-dependent protein kinase, Identification of phosphorylation sites and effect on microtubule assembly
136. Evidence against increased glycoxidation in patients with Alzheimer's disease
137. Normal and abnormal biology of the beta-amyloid precursor protein
138. Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers
139. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
140. Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: Demonstration of an additional 74-kDa component and age-related biochemical modifications
141. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
142. Beta-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: Differential involvement of the calpain/protein kinase C system
143. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology
144. Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease
145. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome
146. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
147. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A
148. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
149. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
150. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
151. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
152. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
153. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments
154. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location
155. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta
156. Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons
157. Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
158. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type
159. Tau as a nucleolar protein in human nonneural cells in vitro and in vivo
160. Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules
161. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly
162. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
163. Proteins of the mammalian mitotic spindle: Phosphorylation/dephosphorylation of MAP-4 during mitosis
164. Elevation of microtubuleassociated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
165. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
166. Mitotic mechanisms in Alzheimer's disease?
167. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation
168. Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease
169. In vivo phosphorylation sites in fetal and adult rat tau
170. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease
171. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines
172. Phosphorylation of native and truncated isoforms of protein tau by the double-stranded DNA-dependent protein kinase (DNA-PK) shows that the primary phosphorylation sites are localized between amino acid residues 212-231 of the longest tau
173. Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells
174. The interrelationship between selective tau phosphorylation and microtubule association
175. Monoclonal antibody PHF-9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments
176. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation